Open Access. Powered by Scholars. Published by Universities.®

Medicinal-Pharmaceutical Chemistry Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 5 of 5

Full-Text Articles in Medicinal-Pharmaceutical Chemistry

In Vivo Evaluation Of A Biomimetic Polymer-Doxorubicin Conjugate For Cancer Therapy, Matthew Skinner, Samantha Mcrae Page, Xiangji Chen, Sangram S. Parelkar, Kaitlyn Wong, Maria Mora, Sallie S. Schneider, Todd S. Emrick May 2014

In Vivo Evaluation Of A Biomimetic Polymer-Doxorubicin Conjugate For Cancer Therapy, Matthew Skinner, Samantha Mcrae Page, Xiangji Chen, Sangram S. Parelkar, Kaitlyn Wong, Maria Mora, Sallie S. Schneider, Todd S. Emrick

UMass Center for Clinical and Translational Science Research Retreat

This poster will describe a novel polymer pro-drug platform designed for conjugation and delivery of chemotherapeutics. Specifically, polymer pro-drugs were prepared from functional polymer zwitterions and doxorubicin (DOX), and evaluated in vivo to assess toxicological, pharmacokinetic and therapeutic properties. The biocompatible polymer scaffold (PolyMPC) consists of zwitterionic phosphorylcholine pendent groups, which mimic the natural hydrophilic moieties of phospholipids in cell membranes, and hydrazone linkages that allow for pH-triggered release of DOX. PolyMPC-DOX pro-drugs were isolated as dry solids using a facile strategy that allows for precise control of molecular weight and DOX incorporation. In vivo toxicity of PolyMPC and PolyMPC-DOX ...


Application Of Diarylhydrazones, Schiff-Bases And Their Saturated Derivatives As Multifunctional Inhibitors Of Amyloid Self-Assembly, Christian Schafer, Sanjukta Ghosh, Marianna Torok, Bela Torok May 2014

Application Of Diarylhydrazones, Schiff-Bases And Their Saturated Derivatives As Multifunctional Inhibitors Of Amyloid Self-Assembly, Christian Schafer, Sanjukta Ghosh, Marianna Torok, Bela Torok

UMass Center for Clinical and Translational Science Research Retreat

A new class of multifunctional small molecule inhibitors of amyloid self-assembly is described. Several compounds, based on the diarylhydrazone scaffold were designed. Forty-four substituted derivatives of this core structure were synthesized using a variety of benzaldehydes and phenylhydrazines and were characterized. The inhibitor candidates were evaluated in multiple assays, including the inhibition of A fibrillogenesis and the disassembly of preformed fibrils. The hydrazone scaffold showed strong activity in inhibiting the amyloid beta self-assembly. The structure-activity relationship revealed that the substituents on the aromatic rings had considerable effect on the overall activity of the compounds. In order to identify possible functional ...


Enhancing Antibiotic Activity Using Nanomaterial-Antibiotic Conjugates, H. Surangi N. Jayawardena, Thareendra De Zoysa, Kalana W. Jayawardana, Scott T. Boiko, Mingdi Yan May 2014

Enhancing Antibiotic Activity Using Nanomaterial-Antibiotic Conjugates, H. Surangi N. Jayawardena, Thareendra De Zoysa, Kalana W. Jayawardana, Scott T. Boiko, Mingdi Yan

UMass Center for Clinical and Translational Science Research Retreat

We demonstrate that streptomycin conjugated on silica nanoparticles (SNP-Str) can be used to effectively target streptomycin-resistant Escherichia coli (E. coli) bacteria by lowering the minimum inhibitory concentration (MIC) of streptomycin up to 2 log folds. Silica nanoparticles were synthesized with an average diameter of 80, 50 and 30 nm, respectively. Streptomycin was then covalently conjugated to SNP using efficient photocoupling chemistry. The MIC for free streptomycin sulfate was recorded as a high 2.0 mg/mL for an engineered Strr mutant E. coli ORN 208. Conjugating the streptomycin to SNP resulted in the decrease in MIC to 161 μg/mL ...


Interactions Of Carbohydrate-Conjugated Nanoparticles With Mycobacterium Smegmatis, Kalana W. Jayawardana, H. Surangi N. Jayawardena, Thareendra De Zoysa, Mingdi Yan May 2014

Interactions Of Carbohydrate-Conjugated Nanoparticles With Mycobacterium Smegmatis, Kalana W. Jayawardana, H. Surangi N. Jayawardena, Thareendra De Zoysa, Mingdi Yan

UMass Center for Clinical and Translational Science Research Retreat

Mycobacterium smegmatis is a non-pathogenic microorganism and has been widely used as a model organism to study infections caused by M. tuberculosis and other mycobacterial pathogens. We report that nanoparticles conjugated with selected carbohydrate show a striking increase in the surface adherence by M. smegmatis. This applies to silica nanoparticles and magnetic nanoparticles ranging from 100 nm to 5 nm. Under the same experimental conditions, minimum adhesion was observed for unfunctionalized nanoparticles. The synthesis and characterization of the glyconanoparticles will be presented. The finding is applied to imaging M. smegmatis infected lung epithelial cells, and the results will be discussed.


Synthesis Of Thiophene Analogs As Potential Antagonists Of Chemokine Receptor Type 4 (Cxcr4), Francisco Javier Garcia Jr. Apr 2014

Synthesis Of Thiophene Analogs As Potential Antagonists Of Chemokine Receptor Type 4 (Cxcr4), Francisco Javier Garcia Jr.

Georgia State Undergraduate Research Conference

No abstract provided.